Bartlett & Co Wealth Management’s Fractyl Health GUTS Stock Holding History

Bartlett & Co Wealth Management’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.9K	Buy	+25,000	New	+$17.8K	﹤0.01%	889

Other funds holding GUTS

Accredited Investors Edina, Minnesota $2.31B AUM 33.7% 1-Year Est. Return

Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

TFC Financial Management Boston, Massachusetts $902M AUM 21.74% 1-Year Est. Return

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

Bartlett & Co Wealth Management's GUTS Position: Q2 2026 in Review

Bartlett & Co Wealth Management opened a new position in Fractyl Health (GUTS) in Q2 2026: 25,000 shares worth $19.9K. The stake represents ﹤0.01% of the portfolio and ranks #889 among its holdings.

13 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

Bartlett & Co Wealth Management held 25,000 shares of Fractyl Health worth $19.9K as of Q2 2026.
Fractyl Health was a new Bartlett & Co Wealth Management position in Q2 2026.
Fractyl Health made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #889 holding.
13 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.